Garc’a-Delaney C, S‡nchez-GarcŽs Mç, Figueiredo R, S‡nchez-Torres A, Gay-Escoda C. Clinical significance of interleukin-1 genotype in smoking patients as a predictor of peri-implantitis: A case-control study. Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20 (6):e737-43.  

 

 

doi:10.4317/medoral.20655

http://dx.doi.org/doi:10.4317/medoral.20655

 

 

 

1. Cosyn J, Christiaens V, Koningsveld V, Coucke PJ, De Coster P, De Paepe A, et al. An Exploratory Case-Control Study on the Impact of IL-1 Gene Polymorphisms on Early Implant Failure. Clin Implant Dent Relat Res. 2014 Jul 26. [Epub ahead of print].

 

2. Liao J, Li C, Wang Y, Ten MH, Sun X, Tian A, et al. Meta-analysis of the association between common interleukin-1 polymorphisms and dental implant failure. Mol Biol Rep. 2014;41:2789-98.
http://dx.doi.org/10.1007/s11033-014-3133-6

 

3. Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant disease. J Clin Periodontol. 2008;35:286-91.
http://dx.doi.org/10.1111/j.1600-051X.2008.01274.x

 

4. Lang NP, Berglundh T. Working Group 4 of the Seventh European Workshop on Periodontology: periimplant diseases: where are we now? Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011;38:178-81.
http://dx.doi.org/10.1111/j.1600-051X.2010.01674.x

 

5. Heitz-Mayfield L. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304.
http://dx.doi.org/10.1111/j.1600-051X.2008.01275.x

 

6. Kornman KS. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr. 2006;83:475S-83S.

 

7. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003;74:391-401.
http://dx.doi.org/10.1902/jop.2003.74.3.391

 

8. Andreiotelli M, Koutayas SP, Madianos PN, Strub JR. Relationship between interleukin-1 genotype and peri-implantitis: a literature review. Quintessence Int. 2008;39:289-98.

 

9. Greenstein G, Hart TC. Clinical utility of a genetic susceptibility test for severe periodontitis. A clinical evaluation. J Am Dent Assoc. 2002;133:452-9.
http://dx.doi.org/10.14219/jada.archive.2002.0203

 

10. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics. 1994;19:382-4.
http://dx.doi.org/10.1006/geno.1994.1076

 

11. Jansson H, Hamberg K, De Bruyn H, Bratthall G. Clinical consequences of IL-1 genotype on early implant failures in patients under periodontal maintenance. Clin Implant Dent Relat Res. 2005;7:51-9.
http://dx.doi.org/10.1111/j.1708-8208.2005.tb00047.x

 

12. Koldsland OC, Scheie AA, Aass AM. Prevalence of peri-implantitis related to severity of the disease with different degrees of bone loss. J Periodontol. 2010;81:231-8.
http://dx.doi.org/10.1902/jop.2009.090269

 

13. Mombelli A, van Oosten MA, Schurch E, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987;2:145-51.
http://dx.doi.org/10.1111/j.1399-302X.1987.tb00298.x

 

14. von Elm E, Altman DG, Egger M, Pocock SJ, G¿tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-7.
http://dx.doi.org/10.1016/S0140-6736(07)61602-X

 

15. Hamdy A, Ebrahem M. The effect of interleukin-1 allele 2 genotype (IL-1a -889 and IL-1b +3954) on the individual«s susceptibility to peri-implantitis: case-control study. J Oral Implantol. 2011;37:325-34.
http://dx.doi.org/10.1563/AAID-JOI-D-09-00117.1

 

16. Lindhe J, Meyle J. Peri-implant disease: consensus report of the sixth european workshop on periodontology. J Clin Periodontol. 2008;35:282-5.
http://dx.doi.org/10.1111/j.1600-051X.2008.01283.x

 

17. Quirynen M, De Soete M, Van Steenberghe D. Infectious risks for oral implants: a review of the literature. Clin Oral Implants Res. 2002;13:1-19.
http://dx.doi.org/10.1034/j.1600-0501.2002.130101.x

 

18. Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE. The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: a systematic review. J Clin Periodontol. 2007;34:305-17.
http://dx.doi.org/10.1111/j.1600-051X.2007.01055.x

 

19. Renvert S, Persson R. Periodontitis as a potential risk factor for peri-implantitis. J Clin Periodontol. 2009;36:9-14.
http://dx.doi.org/10.1111/j.1600-051X.2009.01416.x

 

20. Schou S, Holmstrup P, Worthington HV, Esposito M. Outcome of implant therapy in patients with previous tooth loss due to periodontitis. Clin Oral Implants Res. 2006;17:104-23.
http://dx.doi.org/10.1111/j.1600-0501.2006.01347.x

 

21. Dereka X, Mardas N, Chin S, Petrie A, Donos N. A systematic review on the association between genetic predisposition and dental implant biological complications. Clin Oral Implants Res. 2012;23:775-88.
http://dx.doi.org/10.1111/j.1600-0501.2011.02329.x

 

22. Huynh-Ba G, Lang NP, Tonetti MS, Zwahlen M, Salvi GE. Association of the composite IL-1 genotype with peri-implantitis: a systematic review. Clin Oral Implants Res. 2008;19:1154-62.
http://dx.doi.org/10.1111/j.1600-0501.2008.01596.x

 

23. Lachmann S, Kimmerle-Muller E, Axmann D, Scheideler D, Weber H, Haas R. Association between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype. A Cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res. 2007;18:212-23.
http://dx.doi.org/10.1111/j.1600-0501.2006.01322.x

 

24. Heitz-Mayfield L, Huynh-Ba G. History of treated periodontitis and smoking as risk for implant therapy. Int J Oral Maxillofac Implants. 2009;24:39-68.

 

25. Rodr’guez-Arteta OF, Figueiredo R, Valmaseda-Castellon E, Gay-Escoda C. Postoperative complications in smoking patients treated with implants: a retrospective study. J Oral Maxillofac Surg. 2011;69:2152-7.
http://dx.doi.org/10.1016/j.joms.2011.02.082

 

26. Strietzel FP, Reichart PA, Kale A, Kulkarni M, Wegner B, Kuchler I. Smoking interferes with the prognosis of dental implant treatment: a systematic review and meta-analysis. J Clin Periodontol. 2007;34:523-44.
http://dx.doi.org/10.1111/j.1600-051X.2007.01083.x

 

27. Rinke S, Ohl S, Ziebolz D, Lange K, Eickholz P. Prevalence of periimplant disease in partially edentulous patients: a practice-based cross-sectional study. Clin Oral Implants Res. 2011;22:826-33.
http://dx.doi.org/10.1111/j.1600-0501.2010.02061.x

 

28. Feloutzis A, Lang NP, Tonetti MS, BŸrgin W, BrŠgger U, Buser D, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implants Res. 2003;14:10-7.
http://dx.doi.org/10.1034/j.1600-0501.2003.140102.x

 

29. Gruica B, Wang HY, Lang N, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res. 2004;15:393-400.
http://dx.doi.org/10.1111/j.1600-0501.2004.01026.x